11 Patents
- US123835212025Treatment of Diseases by Concurrently Eliciting Remyelination Effects and Immunomodulatory Effects Using Selective RXR Agonists
Trustees Of Dartmouth College
0 cites - 0 cites
- US117865552023RAR Selective Agonists in Combination with Immune Modulators for Cancer Immunotherapy
Io Therapeutics, Inc.
0 cites - US117795582023Receptor Subtype and Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
Io Therapeutics, Inc.
0 cites - US117379962023Immunomodulatory and Differentiating Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
Io Therapeutics, Inc.
0 cites - US116908312023Treatment of Autoimmune Diseases with Combinations of RXR Agonists and Thyroid Hormones
IO Therapeutics, Inc.
0 cites - US116908322023Treatment of Autoimmune Diseases with Combinations of RXR Agonists and Thyroid Hormones
IO Therapeutics
0 cites - US116482222023Use of Cyp26-resistant RAR Alpha Selective Agonists in the Treatment of Cancer
The Johns Hopkins Univercity
0 cites - US116482232023Receptor Subtype and Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
Io Therapeutics, Inc.
0 cites - 0 cites
- 0 cites